Biography:

Dr. Wei Wu received his medical and research training in cancer biology in China and completed postdoctoral training in the United States and Canada. He is actively engaged in systems and computational cancer biology, focusing on gene regulatory networks mediated by both protein-coding and non-coding transcripts in the mammalian genome. His current research emphasizes multi-omics approaches to unravel the complexities of tumor heterogeneity and evolution, as well as the development of AI-based models to understand the mechanisms of drug resistance. His ultimate goal is to explore the cancer genome to identify potential "actionable and druggable" small-molecule therapies for cancer treatment.